YNP CLINICAL RESEARCH LTD
Significant control: Narinder Banga (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ynp Clinical Research Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Ynp Clinical Research Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
YNP CLINICAL RESEARCH LTD is an active private limited company (company number 13483958) incorporated on 29 June 2021, registered in Walsall. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £12k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 97% on the prior period (£6,092).
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Mrs Narinder Banga
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 29 June 20215 yrs ago
- Next accounts due
- 30 March 2027in 154 days
- Confirmation statement due
- 13 July 2027in 259 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £12k | — | — | £11k | — | — | 2 |
| 30 June 2024 | £6,092 | — | — | £1,550 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £12,013 at 30 June 2025
- Net assets up 10% or more on the prior period+97.2% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.1
- Incorporated five or more years agoIncorporated 29 June 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 259 days
- Next accounts duein 154 days
- Accounts period endNet assets £12k · micro accounts
- Accounts period endNet assets £6,092 · micro accounts
- Incorporated
Similar companies in Birmingham
- NEWAVX LTDBirmingham · inc. Jun 2021
- PHAGIOTIC LIMITEDTamworth · inc. May 2021
- CECOLYSE LIMITEDSutton Coldfield · inc. May 2021
- IBIOTECH LTDWolverhampton · inc. Sept 2021
- HEALOME THERAPEUTICS LTDBirmingham · inc. Jan 2021
- SAFE WASTE TECHNOLOGY LIMITEDStourbridge · inc. Dec 2020
All companies incorporated on 29 June 2021 · in Jun 2021.
Reminders for YNP CLINICAL RESEARCH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.